These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30298378)

  • 1. I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
    Verburg FA; Giovanella L; Iakovou I; Konijnenberg MW; Langsteger W; Lassmann M; Mihailovic J; Luster M
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2247-2249. PubMed ID: 30298378
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.
    Lichtenstein M
    J Clin Oncol; 2018 Jun; 36(18):1887. PubMed ID: 29723090
    [No Abstract]   [Full Text] [Related]  

  • 3. Inconclusive Analysis of the Connection Between Secondary Hematologic Malignancies and Radioiodine Treatment.
    Kreissl MC; Grande E
    J Clin Oncol; 2018 Jun; 36(18):1882-1883. PubMed ID: 29723089
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer.
    Padma S; Sundaram PS
    J Cancer Res Ther; 2016; 12(3):1109-1113. PubMed ID: 28054519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer.
    Hakala TT; Sand JA; Jukkola A; Huhtala HS; Metso S; Kellokumpu-Lehtinen PL
    Int J Clin Oncol; 2016 Apr; 21(2):231-239. PubMed ID: 26410770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Focus on Rare Hematologic Malignancies Misleads Risk-Benefit Assessment of Radioiodine Therapy of Thyroid Cancer.
    Doss M
    J Clin Oncol; 2018 Jun; 36(18):1883-1884. PubMed ID: 29723093
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of Nonthyroidal Primary Malignancy and the Association with (131)I Treatment in Patients with Differentiated Thyroid Cancer.
    Hirsch D; Shohat T; Gorshtein A; Robenshtok E; Shimon I; Benbassat C
    Thyroid; 2016 Aug; 26(8):1110-6. PubMed ID: 27302111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Treatment of Well-Differentiated Thyroid Carcinoma.
    Paschke R; Lincke T; Müller SP; Kreissl MC; Dralle H; Fassnacht M
    Dtsch Arztebl Int; 2015 Jun; 112(26):452-8. PubMed ID: 26205749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioactive iodine treatment for differentiated thyroid carcinoma in Japan.
    Okamoto T
    Surgery; 2010 Mar; 147(3):432-3. PubMed ID: 20176244
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
    Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
    Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium as an adjuvant of iodine-131 uptake when treating patients with well-differentiated thyroid carcinoma.
    Pons F; Carrió I; Estorch M; Ginjaume M; Pons J; Milian R
    Clin Nucl Med; 1987 Aug; 12(8):644-7. PubMed ID: 3117471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The choice of a radioactive isotope for treatment of carcinoma of the thyroid.
    PHILLIPS AF
    Br J Radiol; 1957 May; 30(353):247-53. PubMed ID: 13426504
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of radioiodine in the treatment of carcinoma of the thyroid; Mackenzie Davidson memorial lecture.
    HILTON G
    Br J Radiol; 1956 Jun; 29(342):297-310. PubMed ID: 13316018
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the thyroid gland: aspects of radioiodine and hormone therapy.
    ROBINSON T; ANDREWS JR
    Med Ann Dist Columbia; 1960 Apr; 29():209-13. PubMed ID: 14438001
    [No Abstract]   [Full Text] [Related]  

  • 16. [The initial treatment of patients with differentiated thyroid carcinoma; consensus and controversies].
    Smit JW
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):454-7. PubMed ID: 11913107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary cancer following differentiated thyroid cancer.
    Berthe E; Henry-Amar M; Michels JJ; Rame JP; Berthet P; Babin E; Icard P; Samama G; Galateau-Sallé F; Mahoudeau J; Bardet S
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):685-91. PubMed ID: 14747959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy for differentiated thyroid carcinoma.
    Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
    Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The investigation and therapy of thyroid carcinoma with radioactive iodine.
    POCHIN EE
    Proc R Soc Med; 1953 Apr; 46(4):233-5. PubMed ID: 13055869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.